Return to Home Historical Trends > Interpret

Interpretation of Historical Trends Data

Historical Trends (2002-2021)

Incidence, District of Columbia, Prostate, All Races (incl Hisp), All Ages, Male

Incidence, District of Columbia, Prostate, All Races (incl Hisp), All Ages, Male

Line graph with 20 years and 3 segments
During 2002-2011, the APC1 in the rate of cancer was stable: -0.6 with a 95% confidence interval from -2.6 to 5.6.
During 2011-2014, the APC1 in the rate of cancer was falling: -13.9 with a 95% confidence interval from -19.2 to -4.6.
During 2014-2021, the APC1 in the rate of cancer was stable: 2.3 with a 95% confidence interval from -2.5 to 11.9.
Yearly points:
In 2002, the observed rate was 231.1. The estimated rate was 206.5.
In 2003, the observed rate was 205.6. The estimated rate was 205.1.
In 2004, the observed rate was 181.7. The estimated rate was 203.8.
In 2005, the observed rate was 176.4. The estimated rate was 202.5.
In 2006, the observed rate was 183.2. The estimated rate was 201.2.
In 2007, the observed rate was 234.3. The estimated rate was 199.9.
In 2008, the observed rate was 208.1. The estimated rate was 198.6.
In 2009, the observed rate was 180.9. The estimated rate was 197.3.
In 2010, the observed rate was 195.5. The estimated rate was 196.1.
In 2011, the observed rate was 204.5. The estimated rate was 194.8.
In 2012, the observed rate was 169.7. The estimated rate was 167.8.
In 2013, the observed rate was 128.4. The estimated rate was 144.6.
In 2014, the observed rate was 128.7. The estimated rate was 124.5.
In 2015, the observed rate was 119.5. The estimated rate was 127.4.
In 2016, the observed rate was 129.2. The estimated rate was 130.4.
In 2017, the observed rate was 150.6. The estimated rate was 133.4.
In 2018, the observed rate was 141.0. The estimated rate was 136.5.
In 2019, the observed rate was 139.3. The estimated rate was 139.7.
In 2020, the observed rate was 118.9. The estimated rate was N/A.
In 2021, the observed rate was 137.6. The estimated rate was 146.3.

Notes: